Cancer is a difficult disease to treat, largely because traditional treatments have targeted both cancerous and healthy cells. New advancements in precision medicine and genomic testing aim to change that, making treatments more targeted toward just the unhealthy cells.
The move towards precision medicine is gaining more traction though the project faces limitations. One area that we can anticipate will be influenced by precision medicine programs as healthcare IT technologies continue to spread in the healthcare market is in EMR/EHR solution integration and functionality.
In a recent topic covered by NPR in Health News, titled Electronic Health Records May Help Customize Medical Treatments, expresses how healthcare is continuously uncovering the benefit of population health and the potential for a database of medical records to be mined in order to help shape an individual’s treatment.
Your clinical staff must refer to paper, faxed, and/or scanned documents because clinical data found within these documents are not found in the EHR. Your interruptions to the workflow, that was carefully designed into the EHR, costs time, money, and frustration and it may even insert errors into the healthcare decision making process.
There are six key principles of the federal Precision Medicine Initiative (PMI). PMI was a federal initiative announced by President Obama in 2015 and was incorporated into the 2016 budget. The mission statement for PMI is “to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care.”
The System Improvement Agreement (SIA)
In our previous post, we discussed what happens when your program receives a letter from either the United Network for Organ Sharing (UNOS) or the Center for Medicare and Medicaid Services (CMS) and your program's initial response. Today we will focus on what happens if CMS does not accept your mitigating factors application.